Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. SNBR
SNBR logo

SNBR Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Sleep Number Corp (SNBR) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
1.410
1 Day change
2.92%
52 Week Range
13.940
Analysis Updated At
2026/04/10
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Sleep Number Corp (SNBR) is not a good buy for a beginner, long-term investor with $50,000-$100,000 available for investment. The stock is currently in a bearish trend with no strong positive catalysts, weak financial performance, and neutral sentiment from hedge funds and insiders. Analysts have recently lowered price targets, and there is no significant news or congress trading data to suggest a turnaround. Given the user's impatience and preference for long-term investments, this stock does not align with their goals.

Technical Analysis

The stock is in a bearish trend with SMA_200 > SMA_20 > SMA_5. The RSI is neutral at 34.122, and MACD is slightly positive but not strong enough to indicate a reversal. Key support levels are at 1.182 and 0.839, with resistance at 2.294 and 2.637. The pre-market price of 1.37 is below the pivot level of 1.738, indicating further downside potential.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

The low put-call ratios indicate a lack of bearish sentiment in options trading, but this is not enough to counteract the overall negative outlook.

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
9
Buy
3

Positive Catalysts

  • No significant positive catalysts identified. The MACD is slightly positive, and there is a 14.33% chance of a price increase in the next month, but these are not strong enough to justify a buy.

Neutral/Negative Catalysts

  • Financial performance is weak, with declining revenue (-7.81% YoY) and negative EPS (-2.55). Gross margin has also dropped (-2.46% YoY). Hedge funds and insiders are neutral, and there is no recent news or congress trading data to suggest a turnaround.

Financial Performance

In Q4 2025, revenue dropped by 7.81% YoY to $347.39M. Net income increased significantly but remains negative at -$58.51M. EPS improved to -2.55, but it is still negative. Gross margin declined to 58.39%. Overall, the financials indicate a struggling company with no clear signs of recovery.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analysts have a neutral rating on SNBR. UBS and Piper Sandler recently lowered their price targets significantly, citing weak sales performance despite some progress in marketing and product launches. This indicates a lack of confidence in the stock's near-term recovery.

Wall Street analysts forecast SNBR stock price to rise
2 Analyst Rating
Wall Street analysts forecast SNBR stock price to rise
0 Buy
2 Hold
0 Sell
Hold
Current: 1.370
sliders
Low
5
Averages
5.5
High
6
Current: 1.370
sliders
Low
5
Averages
5.5
High
6
UBS
Dan Silverstein
Neutral
downgrade
$10 -> $4
AI Analysis
2026-03-13
Reason
UBS
Dan Silverstein
Price Target
$10 -> $4
AI Analysis
2026-03-13
downgrade
Neutral
Reason
UBS analyst Dan Silverstein lowered the firm's price target on Sleep Number to $4 from $10 and keeps a Neutral rating on the shares.
Piper Sandler
Neutral
downgrade
$12 -> $5
2026-03-13
Reason
Piper Sandler
Price Target
$12 -> $5
2026-03-13
downgrade
Neutral
Reason
Piper Sandler lowered the firm's price target on Sleep Number to $5 from $12 and keeps a Neutral rating on the shares despite a Q4 revenue and EBITDA beat. While the company appears to be making progress with marketing spend and new product launches, this hasn't translated to an improvement in sales at this point, the firm argues.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for SNBR
Unlock Now

People Also Watch